Pancreatic cancer MRI: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}}{{Faizan}} | {{CMG}}{{AE}}{{PSD}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
On | On abdominal MRI, pancreatic cancer appears as hypointense with slower enhancement than normal pancreatic tissue. | ||
==MRI== | ==MRI== | ||
Signal characteristics include: | Signal characteristics include: | ||
Revision as of 20:28, 21 August 2015
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer MRI On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]Faizan Sheraz, M.D. [3]
Overview
On abdominal MRI, pancreatic cancer appears as hypointense with slower enhancement than normal pancreatic tissue.
MRI
Signal characteristics include:
- T1: hypo intense c.f. normal pancreas
- T1 FS: hypo intense c.f. normal pancreas
- T1 + C (Gd): slower enhancement than normal pancreas, therefore dynamic injection with arterial phase imaging with fat saturation is ideal
- T2/FLAIR: variable (therefore not very useful) depending on the amount of reactive desmoplastic reaction [1]
References
- ↑ Pancreatic ductal carcinoma. Dr Ahmed Abd Rabou and Dr Frank Gaillard et al. Radiopedia.org 2015. http://radiopaedia.org/articles/pancreatic-ductal-carcinoma